Approval · Notice of Compliance 37160 · 2026
DENOZA: Notice of Compliance 37160
Issued March 23, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 37160
- Date
- March 23, 2026
- Company
- Apotex Inc.Toronto, Ontario, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Canadian reference product
- PROLIA
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| DENOZA | 02566265 | Marketed |
Medicinal ingredients
- DENOSUMAB 60 MG per ML